That’s good news, of course. But with so many different approaches to prostate cancer treatment, each with its own benefits and risks, weighing your options and choosing the most appropriate treatment can be complicated. The right treatment for each man depends on his stage of cancer and how aggressively the cancer cells are growing. For example, a man with early prostate cancer that is slow growing may opt for watchful waiting. Another man with early prostate cancer that is growing aggressively might choose surgery plus radiation, or another combination of therapies.
His father's prostate cancer changed tennis legend John McEnroe, who turned 50 in February. McEnroe used to have at least one thing in common with ordinary guys: He rarely saw a doctor or gave his own health a lot of thought. That all changed five years ago, when his dad, now 74, was diagnosed with prostate cancer.
"It really raised my awareness level," says the four-time U.S. Open champ. He scheduled his first prostate-specific antigen test -- a screening test for prostate cancer that's also called...
Watchful Waiting: Active Surveillance of Prostate Cancer
Thanks to screening and early detection, many prostate cancers are first detected long before they pose a threat. Indeed, many of the cancers detected by PSA tests and biopsies prove to be very early cancers or so slow-growing that they never pose a life-threatening danger.
Because of early diagnosis, the best approach for a growing number of men is to monitor the cancer for signs that it is getting worse. Called active surveillance or “watchful waiting,” this strategy allows men with early-stage or very slow growing prostate cancer to avoid treatment and its side effects -- or actively monitor the disease and to take action if the cancer grows or spreads.
Experts say this approach could be appropriate for 40% of all men diagnosed with the disease in the U.S.
“Active surveillance is a choice to consider if your cancer is a less aggressive type, occurs only in a small part of the prostate gland, and has not spread outside the gland,” says Peter Carroll, MD, MPH, professor and chair of urology at the University of California, San Francisco. Other good candidates for active surveillance are men who are older or in poor health, when the risks of surgery or radiation may outweigh the benefits.